SELLAS Life Sciences Group Inc SLS shares are falling Wednesday, pulling back after trading higher earlier in the day, as the ...

Sellas Life Sciences remains a 'Strong Sell,' as the REGAL trial delay signals increased risk of failure and diminished ...

ReAlta Life Sciences Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central components of the complement system to potentially ...

Shares of SELLAS Life Sciences Group, Inc. ( SLS) are falling 17 percent on Wednesday morning after the company announced that the pivotal Phase 3 REGAL trial evaluating galinpepimut-S in patients ...

The trio worked together at Womble Bond Dickinson and bring significant intellectual property knowledge to Honigman as the ...

The next major breakthrough in life sciences may have a company’s name attached to it, but increasingly, the story behind ...

The Rhode Island Life Science Hub (RILSH) and the Massachusetts Life Sciences Center (MLSC) today announced they have signed a Memorandum of Understanding (MOU) to work toward a shared regional ...

In the post-pandemic world, the life sciences are taking centre stage. From Boston’s Kendall Square to Singapore’s Biopolis, innovation districts that focus on the life sciences have the potential to ...

Anthropic plans to expand its growing presence in life sciences by investing further in knowledge, talent, partnerships, and ...

This recorded session provides HR and Total Rewards leaders with critical market intelligence to inform 2027 compensation, ...

Wave Life Sciences (WVE) is scheduled to announce Q3 earnings results on Tuesday, October 27th, before market open. The consensus EPS Estimate is -$0.32 (flat Y/Y) and the consensus Revenue Estimate ...

During the third quarter, Alexandria sold assets in each of the big three biotech markets and, so far in October, has agreed ...